Cipla Limited is an Indian multinational pharmaceutical company that is headquartered in Mumbai, Maharashtra. The company is primarily known for producing generic drugs for various therapeutic uses.

Shares of Cipla are set to be in focus on Friday after the company received final approval from the U.S. Food and Drug Administration for its New Drug Application (NDA) for Nilotinib capsules ...

Cialis and its generic counterpart, tadalafil, have Food and Drug Administration (FDA) approval to treat erectile dysfunction. See our most trusted places to get this medication discreetly at the ...

VWAP, or volume-weighted average price, is a technical analysis tool used primarily on intraday charts. It provides a benchmark for the average price a security has traded at during the day ...

Cost: Roman offers both brand-name Cialis and generic Cialis (tadalafil) that you can take as needed or on a daily basis at a lower dose. Here’s a breakdown of what you can expect to pay for ...

Premium Quality Power IPO Day 2 Highlights: The subscription period for the Quality Power IPO is scheduled from Friday, February 14, to Tuesday, February 18. Quality Power IPO Day 2 Highlights ...

Cipla share price: In a press release issued after market hours on February 20, Cipla announced that it has received approval for Nilotinib capsules in 50 mg, 150 mg, and 200 mg strengths. The oral ...

Cipla finished the day at Rs 1464.15, showing a fall of 1.22% in its market value. Cipla's shares are currently priced at Rs 1465.95, reflecting a 1.09% decrease today, alongside a return of 3.38% ...

Erectile dysfunction meds, like Viagra and Cialis, can help you get and keep an erection. However, each has different side effects, dosage schedules, and other factors. Here, we look at how they ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

Mumbai: Cipla Limited has announced that the Company has completed an investment of approx. ZAR 900 million in Cipla Medpro South Africa Proprietary Limited, South Africa, a wholly owned subsidiary in ...